​

Edgewise Therapeutics (EWTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Edgewise Therapeutics Revenue Highlights

00

Edgewise Therapeutics Revenue by Period

Edgewise Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Edgewise Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Edgewise Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.25M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Edgewise Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Edgewise Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HOWLWerewolf Therapeutics$19.94M$1.14M
RVMDRevolution Medicines$11.58M-
IKNAIkena Oncology$9.16M-
IPSCCentury Therapeutics$2.23M$791.00K
DSGNDesign Therapeutics--
CGEMCullinan Oncology--
BDTXBlack Diamond Therapeutics--
CCCCC4 Therapeutics--
ACETAdicet Bio--
PASGPassage Bio--
CELCCelcuity--
MLYSMineralys Therapeutics--
VORVor Biopharma--
EWTXEdgewise Therapeutics--
XLOXilio Therapeutics-$2.36M

EWTX Revenue FAQ

What is Edgewise Therapeutics’s yearly revenue?

Edgewise Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. EWTX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Edgewise Therapeutics’s quarterly revenue?

Edgewise Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). EWTX's quarterly revenue for Q4 2023 was $2.25M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Edgewise Therapeutics’s revenue growth rate?

Edgewise Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.